NCT06907004

Brief Summary

Background: Hematopoietic stem cell transplantation (HSCT) is a highly aggressive treatment, which is associated with numerous treatment-related side effects, such as fatigue and decreased functional activity. While recent studies have shown that physical exercise for patients undergoing HSCT is safe and feasible, and has a positive effect on the quality of life, fatigue, and lower limb muscle strength. However, there is no consensus regarding the intensity, type and frequency of exercise program, and few studies mention the patients' experience of exercise barriers and facilitators during HSCT. Therefore, the clinical implementation of exercise program is quite difficult. Purpose: The purpose of this study is to develop a feasible exercise program for hospitalized patients undergoing hematopoietic stem cell transplantation. Methods: Action Research is used to collect quantitative and qualitative data. Through the rolling revision of the exercise program during HSCT, finally develop a feasible exercise program. Expected results: Developing a feasible exercise program for hospitalized patients undergoing hematopoietic stem cell transplantation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 14, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 13, 2023

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

March 19, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 2, 2025

Completed
Last Updated

April 2, 2025

Status Verified

February 1, 2023

Enrollment Period

8 months

First QC Date

March 19, 2025

Last Update Submit

March 31, 2025

Conditions

Keywords

Action researchHematopoietic stem cell transplantationExercise program

Outcome Measures

Primary Outcomes (3)

  • Exercise adherence rate

    Definition: The percentage of prescribed exercise sessions completed by participants during the hematopoietic stem cell transplantation hospitalization period. Measurement Method: 1. Numerator: Number of completed exercise sessions 2. Denominator: Total number of prescribed exercise sessions 3. Unit of Measure: Percentage (%)

    approximately 4-6 weeks

  • Patient Satisfaction Score of the Exercise Program

    Definition: The mean score of a 7-item satisfaction questionnaire using a 5-point Likert scale to evaluate patient's satisfaction with the exercise program. Measurement Method: 1. Tool: 7-item satisfaction questionnaire with 5-point Likert scale Scale Range: 1 (strongly disagree) to 5 (strongly agree) 2. Total Score Calculation: Mean score of all 7 items 3. Unit of Measure: Score on a scale (1-5) Questionnaire Items: 1. Appropriateness of exercise timing 2. Appropriateness of exercise intensity 3. Appropriateness of exercise frequency 4. Appropriateness of exercise type and difficulty level 5. Achievement of exercise goals 6. Satisfaction with personal performance 7. Willingness to continue exercising

    approximately 4-6 weeks

  • Exercise-Related Adverse Events Rate

    Definition: The percentage of exercise sessions with adverse events during the hematopoietic stem cell transplantation hospitalization period. Measurement Method: 1. Numerator: Number of exercise sessions with adverse events 2. Denominator: Total number of completed exercise sessions 3. Unit of Measure: Percentage (%)

    approximately 4-6 weeks

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

First-time hematopoietic stem cell transplantation (HSCT) patients and their primary caregivers, and physical therapists and nurses at Chimei Medical Center.

You may qualify if:

  • First-time hematopoietic stem cell transplantation (HSCT) patients who are ambulatory, their primary caregivers, and physical therapists and nurses participating in the exercise intervention;
  • Age 20 years or older;
  • Capable of understanding and complying with the study objectives;
  • No psychiatric disorders or cognitive impairments.

You may not qualify if:

  • HSCT patients deemed unsuitable for exercise participation based on the attending physician's assessment;
  • HSCT patients at risk of fractures or confined to bed rest due to musculoskeletal conditions.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chimei Medical Center

Tainan, Taiwan, 71004, Taiwan

Location

Related Publications (6)

  • Morishita S, Nakano J, Fu JB, Tsuji T. Physical exercise is safe and feasible in thrombocytopenic patients with hematologic malignancies: a narrative review. Hematology. 2020 Dec;25(1):95-100. doi: 10.1080/16078454.2020.1730556.

    PMID: 32075567BACKGROUND
  • Morishita S, Kaida K, Setogawa K, Kajihara K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K. Safety and feasibility of physical therapy in cytopenic patients during allogeneic haematopoietic stem cell transplantation. Eur J Cancer Care (Engl). 2013 May;22(3):289-99. doi: 10.1111/ecc.12027. Epub 2012 Dec 18.

    PMID: 23252444BACKGROUND
  • Mohammed J, Aljurf M, Althumayri A, Almansour M, Alghamdi A, Hamidieh AA, ElHaddad A, Othman TB, Bazarbachi A, Almohareb F, Alzahrani M, Alkindi SS, Alsharif F, Da'na W, Alhashmi H, Bekadja MA, Al-Shammari SH, El Quessar A, Satti TM, Aljohani N, Rasheed W, Ghavamzadeh A, Chaudhri N, Hashmi SK. Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group. Hematol Oncol Stem Cell Ther. 2019 Sep;12(3):127-132. doi: 10.1016/j.hemonc.2018.12.003. Epub 2019 Jan 11.

    PMID: 30653940BACKGROUND
  • Liang Y, Zhou M, Wang F, Wu Z. Exercise for physical fitness, fatigue and quality of life of patients undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials. Jpn J Clin Oncol. 2018 Dec 1;48(12):1046-1057. doi: 10.1093/jjco/hyy144.

    PMID: 30277514BACKGROUND
  • Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplant. 2011 Sep;46(9):1245-55. doi: 10.1038/bmt.2010.288. Epub 2010 Dec 6.

    PMID: 21132025BACKGROUND
  • Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, Zucker DS, Matthews CE, Ligibel JA, Gerber LH, Morris GS, Patel AV, Hue TF, Perna FM, Schmitz KH. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390. doi: 10.1249/MSS.0000000000002116.

    PMID: 31626055BACKGROUND

Related Links

Study Officials

  • Min-Syuan Yen, Master's Degree

    Chimei Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2025

First Posted

April 2, 2025

Study Start

February 14, 2023

Primary Completion

October 13, 2023

Study Completion

October 13, 2023

Last Updated

April 2, 2025

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to the following reasons: 1. Privacy and confidentiality concerns - The study involves sensitive medical information from HSCT patients and personal experiences from healthcare providers. 2. Ethical restrictions - The informed consent obtained from participants did not include permission for data sharing beyond the research team. 3. Hospital policy compliance - The participating medical center's regulations restrict the sharing of patient-related data to protect patient privacy. 4. Small sample size - With only 24 participants, sharing individual data might risk participant identification, even if anonymized.

Locations